Recent Finacing
Recent Raise
Proteolix is a South San Francisco biotech developing proteasome-targeting oncology drugs, advancing lead candidate carfilzomib through Phase II and III clinical trials to disrupt cancer cell functions.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors